Biosimilars and Bone Health - Episode 2

Managing Treatment Strategies for Osteoporosis Amid Evolving Biologic and Biosimilar Landscape

Jeffrey Curtis, MD, MS, MPH, provides expert perspective for navigating the evolving treatment landscape of osteoporosis and key considerations for biologic and biosimilar utilization.

*Content was developed independently by The Center for Biosimilars® and supported by Sandoz.